Kafatos:Research
From OpenWetWare
(Difference between revisions)
Current revision (09:53, 25 May 2010) (view source) |
|||
| Line 83: | Line 83: | ||
|-valign="top" | |-valign="top" | ||
|style="background:#ffffff"| | |style="background:#ffffff"| | ||
| - | ==BBSRC Research Grant on: Genomic analysis of NF-kappaB signalling in Anopheles gambiae== | + | ==BBSRC Research Grant on:<BR> Genomic analysis of NF-kappaB signalling in Anopheles gambiae== |
<blockquote> | <blockquote> | ||
The innate immune system is the first line of defence against infections in higher organisms. In insects, which like other invertebrate animals lack adaptive immune systems, innate immunity is the only defence system. Innate immunity relies on receptors that recognize specific molecular structures shared between microbes or danger signals generated during an infection. Recognition triggers specific signalling pathways, cellular processes or enzymatic cascades, which activate various effector mechanisms that combat infections. In many cases, the effector mechanisms require de novo production of effector or regulatory proteins, which is usually controlled by transcription factors of the Rel/Nuclear Factor/kappaB (NF-kappaB) family. This BBSRC-funded project aims to dissect the mechanisms of gene expression that are under the control of NF-kappaB signalling pathways in the African mosquito Anopheles gambiae. This mosquito is a vector for animal and human diseases including malaria that is caused by the protozoan parasite Plasmodium. In recent years, thanks to the availability of its genome sequence and development of robust genetics and genomics tools to investigate the gene function, A. gambiae has become a model system to study the interactions between microbes, especially Plasmodium, and the innate immune system.<BR><BR> | The innate immune system is the first line of defence against infections in higher organisms. In insects, which like other invertebrate animals lack adaptive immune systems, innate immunity is the only defence system. Innate immunity relies on receptors that recognize specific molecular structures shared between microbes or danger signals generated during an infection. Recognition triggers specific signalling pathways, cellular processes or enzymatic cascades, which activate various effector mechanisms that combat infections. In many cases, the effector mechanisms require de novo production of effector or regulatory proteins, which is usually controlled by transcription factors of the Rel/Nuclear Factor/kappaB (NF-kappaB) family. This BBSRC-funded project aims to dissect the mechanisms of gene expression that are under the control of NF-kappaB signalling pathways in the African mosquito Anopheles gambiae. This mosquito is a vector for animal and human diseases including malaria that is caused by the protozoan parasite Plasmodium. In recent years, thanks to the availability of its genome sequence and development of robust genetics and genomics tools to investigate the gene function, A. gambiae has become a model system to study the interactions between microbes, especially Plasmodium, and the innate immune system.<BR><BR> | ||
Current revision
| Home | Lab Members | Research | Publications | Contact |
Functional genomics of mosquito vector/malaria parasite interactionsThe Laboratory of Insect Immunogenomics focuses on the study of the major vector of malaria in Africa, Anopheles gambiae and particularly how its innate immune system manipulates and is manipulated by the malaria parasite during its passage through the mosquito. Malaria is one of the main infectious causes of human mortality world-wide, mainly among young children in sub-Saharan Africa. Transmission of the malaria agent, the Plasmodium parasite, requires its cyclical development in two organisms: the human host and the Anopheles mosquito vector. Current disease control methods that aim to either cure the disease in the human body or to control the vector populations are hampered due to increase in drug resistance of the parasite and insecticide resistance of the mosquito. Our underlying conviction is that bringing the power of functional genomics into the study of this biological system will rapidly advance our understanding of mosquito immunity and parasite development. This will be crucial for the development of novel approaches to malaria control that are urgently needed to reinforce and complement the ongoing research into drug, vaccine and insecticide development. |
Genomic approachesTo investigate the genetic armory of the A. gambiae mosquito we have initially used an EST library derived from two immune competent mosquito cell lines to construct DNA microarrays containing approximately 2,500 genes [1]. These arrays permitted for the first time an understanding of the global innate immune responses in adult mosquitoes and cultured cells, as well as the mosquito reaction to Plasmodium infection and mechanisms for refractoriness to the parasite. To increase further the resolution of this powerful technique, we recently constructed DNA microarrays containing approximately 20,000 Anopheles ESTs representing over 9,000 mosquito genes, and work is ongoing to develop an amplicon-based microarray platform encompassing all predicted genes in the mosquito genome. This resource also allows for high throughput production of dsRNAs that can be used for RNAi gene silencing as well as expression of fragments of all predicted mosquito proteins, for use in antibody production. |
Targeted approachesDissecting the mosquito immune pathways. Pioneering studies in the fly Drosophila melanogaster contributed to the detailed understanding of innate immunity and showed that the underlying mechanisms have largely been conserved through the course of metazoan evolution [4]. These studies revealed most of the components of two conserved immune signaling pathways, Toll and Imd, that are utilized by the fly to respond to bacterial and fungal infections (Figure 2A). The availability of the A. gambiae genome sequence [5] previously allowed us to perform a comparative genomic analysis of putative immunity genes between Anopheles and Drosophila [6]. Although the majority of the intracellular components of the Toll and Imd pathways are conserved between the two organisms (Figure 2B), a number of differences – which may have significant impact on immunity mechanisms – were also identified. The most important of these is the absence of the NF-kB-like transcription factor Dif in Anopheles. This suggested that in a functional Toll pathway either REL1 (the ortholog of Dorsal) or REL2 (the ortholog of Relish) might substitute for Dif. We investigated the role of REL2 and other molecules that are possibly implicated in the same signalling pathway in the mosquito immune responses. REL2 regulates the inducible expression of the various antimicrobial peptide genes including CEC1 and the key parasite antagonist, LRIM1 [7]. We showed that the REL2 gene is alternatively spliced, resulting in two protein isoforms that are differentially implicated in defense against Gram-positive or Gram-negative bacteria. Thus, through alternative splicing Anopheles uses a single gene to mediate reactions for which Drosophila employs two genes, Relish and Dif. The REL2 pathway is also involved in the control of Plasmodium parasite infection of the mosquito midgut. Silencing of the pathway drastically increases the parasite numbers that successfully develop into oocysts. |




